Lv11
30 积分 2025-12-08 加入
Reprogramming of Osimertinib-Resistant EGFR-mutant NSCLC: The Pyruvate-Acetaldehyde-Acetate Pathway As a Key Driver of Resistance
1小时前
求助中
VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy
2小时前
已完结
Copper-Oxamate Coordination Polymers Reverse Cuproptosis Resistance in Nonsmall Cell Lung Cancer via Glycolysis Reprogramming
12天前
已完结
Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non-Small Cell Lung Cancer Models
12天前
已完结
YTHDC2 inhibits the resistance of lung cancer to EGFR-TKI through cuproptosis
13天前
已完结
[Shengmai San improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]
15天前
已关闭
Strategies of overcoming osimertinib resistance in EGFR-mutated non-small cell lung cancer
15天前
已完结
Therapeutic Strategies for Overcoming Resistance to EGFR-TKIs Therapy in EGFR-Mutant NSCLC
17天前
已完结
MTF1 attenuates ferroptosis and cuproptosis synergistic potentiation in gastric cancer
28天前
已完结
Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
